HK biotech: AOBiome, Stealth join IPO queue
Bio-technology firms AOBiome Therapeutics and Stealth Biotherapeutics Corp are seeking the greenlight to float in Hong Kong, adding to a fast-growing pipeline from the sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: